|
gptkbp:instanceOf
|
Pharmacological Class
|
|
gptkbp:administeredBy
|
Intramuscular Route (some agents)
Intravenous Route (some agents)
Oral Route
|
|
gptkbp:alsoKnownAs
|
Anxiolytics
|
|
gptkbp:contraindication
|
Acute Narrow-Angle Glaucoma
History of Substance Abuse
Severe Respiratory Insufficiency
|
|
gptkbp:discoveredIn
|
20th Century
|
|
gptkbp:example
|
gptkb:Buspirone
gptkb:Alprazolam
gptkb:Clonazepam
gptkb:Diazepam
gptkb:Lorazepam
gptkb:Duloxetine
gptkb:Escitalopram
gptkb:Sertraline
gptkb:Venlafaxine
gptkb:Chlordiazepoxide
gptkb:Hydroxyzine
gptkb:Propranolol
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Anti-Anxiety Agents
|
|
gptkbp:includes
|
gptkb:Buspirone
gptkb:SSRIs
gptkb:Benzodiazepines
gptkb:Beta_Blockers
gptkb:Hydroxyzine
gptkb:Pregabalin
gptkb:SNRIs
|
|
gptkbp:introducedIn
|
1950s
|
|
gptkbp:mechanismOfAction
|
Enhance GABAergic Transmission
Noradrenaline Reuptake Inhibition
Serotonin Reuptake Inhibition
|
|
gptkbp:monitors
|
Healthcare Professional
|
|
gptkbp:notRecommendedFor
|
Elderly (some agents)
Pregnancy (some agents)
|
|
gptkbp:regulates
|
Prescription Only
|
|
gptkbp:riskFactor
|
Withdrawal
Tolerance
Potential for Abuse
|
|
gptkbp:sideEffect
|
Dizziness
Cognitive Impairment
Dependence
Drowsiness
Withdrawal Symptoms
|
|
gptkbp:usedFor
|
gptkb:Insomnia
gptkb:Generalized_Anxiety_Disorder
gptkb:Panic_Disorder
gptkb:Social_Anxiety_Disorder
Anxiety Disorders
Muscle Spasms
|
|
gptkbp:bfsParent
|
gptkb:D002409
|
|
gptkbp:bfsLayer
|
6
|